WCLC 2025 - Posters & ePosters-P3.18.51 Anlotinib Combined With PD-1 Blockade and Platinum Doublet Chemotherapy for PSC as First Line Treatment

P3.18.51 Anlotinib Combined With PD-1 Blockade and Platinum Doublet Chemotherapy for PSC as First Line Treatment

Asset Subtitle

Yongsheng Wang

Meta Tag

Speaker Yongsheng Wang

Topic Clinical Trials in Progress